Wordt geladen...
Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1.7-hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human CNGB3 gene, for treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensit...
Bewaard in:
Gepubliceerd in: | Hum Gene Ther Clin Dev |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Mary Ann Liebert, Inc.
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851180/ https://ncbi.nlm.nih.gov/pubmed/27003752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/humc.2015.163 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|